These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21053156

  • 1. Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development.
    Waugh JM, Lee J, Dake MD, Browne D.
    Methods Mol Biol; 2011; 683():553-72. PubMed ID: 21053156
    [Abstract] [Full Text] [Related]

  • 2. Experiences with CPP-Based Self Assembling Peptide Systems for Topical Delivery of Botulinum Toxin.
    Lee J, Kennedy P, Waugh JM.
    Methods Mol Biol; 2015; 1324():397-415. PubMed ID: 26202285
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic applications of cell-penetrating peptides.
    Johnson RM, Harrison SD, Maclean D.
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P, Andaloussi SE, Langel U.
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [Abstract] [Full Text] [Related]

  • 5. Classes and prediction of cell-penetrating peptides.
    Lindgren M, Langel U.
    Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
    [Abstract] [Full Text] [Related]

  • 6. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA, Taghibiglou C, Azizi E, Farboud ES.
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [Abstract] [Full Text] [Related]

  • 7. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L, Divita G.
    Methods Mol Biol; 2011 Nov; 683():349-60. PubMed ID: 21053142
    [Abstract] [Full Text] [Related]

  • 8. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
    Dohmen C, Wagner E.
    Methods Mol Biol; 2011 Nov; 683():453-63. PubMed ID: 21053149
    [Abstract] [Full Text] [Related]

  • 9. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
    Jha D, Mishra R, Gottschalk S, Wiesmüller KH, Ugurbil K, Maier ME, Engelmann J.
    Bioconjug Chem; 2011 Mar 16; 22(3):319-28. PubMed ID: 21319732
    [Abstract] [Full Text] [Related]

  • 10. Industrial-scale manufacturing of a possible oligonucleotide cargo CPP-based drug.
    Tedebark U, Scozzari A, Werbitzky O, Capaldi D, Holmberg L.
    Methods Mol Biol; 2011 Mar 16; 683():505-24. PubMed ID: 21053153
    [Abstract] [Full Text] [Related]

  • 11. Intracellular delivery of nanoparticles with CPPs.
    Sawant R, Torchilin V.
    Methods Mol Biol; 2011 Mar 16; 683():431-51. PubMed ID: 21053148
    [Abstract] [Full Text] [Related]

  • 12. Cell-penetrating peptides: breaking through to the other side.
    Koren E, Torchilin VP.
    Trends Mol Med; 2012 Jul 16; 18(7):385-93. PubMed ID: 22682515
    [Abstract] [Full Text] [Related]

  • 13. Cell-penetrating peptides: design, synthesis, and applications.
    Copolovici DM, Langel K, Eriste E, Langel Ü.
    ACS Nano; 2014 Mar 25; 8(3):1972-94. PubMed ID: 24559246
    [Abstract] [Full Text] [Related]

  • 14. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N, Bech Nielsen EJ, Nakakubo T, Aoyama Y, Rahbek UL, Pedersen BL, Takeda-Morishita M.
    J Pharm Sci; 2016 Feb 25; 105(2):747-753. PubMed ID: 26869427
    [Abstract] [Full Text] [Related]

  • 15. Emerging landscape of cell penetrating peptide in reprogramming and gene editing.
    Liu H, Zeng F, Zhang M, Huang F, Wang J, Guo J, Liu C, Wang H.
    J Control Release; 2016 Mar 28; 226():124-37. PubMed ID: 26849918
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E).
    Martín I, Teixidó M, Giralt E.
    Chembiochem; 2011 Apr 11; 12(6):896-903. PubMed ID: 21365733
    [Abstract] [Full Text] [Related]

  • 17. Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.
    Bode SA, Thévenin M, Bechara C, Sagan S, Bregant S, Lavielle S, Chassaing G, Burlina F.
    Chem Commun (Camb); 2012 Jul 21; 48(57):7179-81. PubMed ID: 22692031
    [Abstract] [Full Text] [Related]

  • 18. Drug delivery with nanospherical supramolecular cell penetrating peptide-taxol conjugates containing a high drug loading.
    Tian R, Wang H, Niu R, Ding D.
    J Colloid Interface Sci; 2015 Sep 01; 453():15-20. PubMed ID: 25956129
    [Abstract] [Full Text] [Related]

  • 19. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
    Shiraishi T, Nielsen PE.
    Methods Mol Biol; 2011 Sep 01; 683():391-7. PubMed ID: 21053145
    [Abstract] [Full Text] [Related]

  • 20. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.
    Soler M, González-Bártulos M, Figueras E, Ribas X, Costas M, Massaguer A, Planas M, Feliu L.
    Org Biomol Chem; 2015 Feb 07; 13(5):1470-80. PubMed ID: 25474438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.